Home   >  
Cell Cycle/DNA Damage
  >  
Aurora
  >   Ilorasertib hydrochloride
Ilorasertib hydrochloride Chemical Structure

Ilorasertib hydrochloride

Data Sheet For research use only. Not for human use.
Cat. No. :BCP45536CAS No. :1847485-91-9Purity:98%
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 1847485-91-9 Cat. No. BCP45536
Related Products 1227939-82-3(Ilorasertib)
Name Ilorasertib hydrochloride
Synonyms ABT348; ABT-348; ABT 348; Abbott 968660; Abbott-968660;ABT-348 hydrochloride;
SMILES C1=CC(=CC(=C1)F)NC(=O)NC2=CC=C(C=C2)C3=CSC4=C3C(=NC=C4C5=CN(N=C5)CCO)N.Cl
Chemical Name
Formula C25H22ClFN6O2S M. Wt 525.0
Purity 98% Storage Store at 4-8°C
Description Ilorasertib, also know as ABT-348, is a novel, potent and orally bioavailable inhibitor of the Aurora kinases as well as the VEGF and PDGF families of receptor tyrosine kinases and is currently in Phase I clinical trials. ABT-348 has nanomolar potency (IC50) for inhibiting binding and cellular auto-phosphorylation of Aurora B (7 and 13 nM), C (1 and 13 nM) and A (120 and 189 nM). Based upon its unique spectrum of activity, ABT 348 was evaluated and found effective in representative solid tumor (HT1080 and MiaPaCa, tumor stasis) and hematological malignancy (RS4;11, regression) xenografts. These results provide the rationale for clinical assessment of ABT-348 as a therapeutic agent in the treatment of cancer.
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Ilorasertib hydrochloride supplier,Ilorasertib hydrochloride purchase,Ilorasertib hydrochloride manufacturer,Ilorasertib hydrochloride distributor,Ilorasertib hydrochloride cost,Ilorasertib hydrochloride buy,Ilorasertib hydrochloride for sale

0086-13720134139